Deed #2: Pharmacogenetic test
The efficacy and safety of pharmacotherapy can be enhanced with pharmacogenetic tests. Therefore DRA offers to all of its employees a pharmacogenetic test which allows tailoring of pharmacotherapy individually.
The efficacy and safety of many pharmaceutical substances are highly dependent on the genome of each individual. Knowing a person’s genome – i.e. genotype – allows personalized pharmacotherapy and dose. The result of a pharmacogenetic test remains valid throughout one’s life: it’s a one-time investment in safe pharmacotherapy.
A pharmacogenetic test by Synlab and Abomics is now available at all Cityterveys clinics for a special price of €239. The offer is valid through October 2017 (offer code DRA15).
More DRA's good deeds
Deed will be published 28.11.2017
Deed will be published 4.12.2017
Deed will be published 10.12.2017